Relationship between vascularity, age and survival in non small-cell lung cancer

被引:63
作者
Chandrachud, LM
Pendleton, N
Chisholm, DM
Horan, MA
Schor, AM
机构
[1] UNIV DUNDEE, DEPT DENT SURG & PERIODONTOL, SCH DENT, DUNDEE DD1 4HR, SCOTLAND
[2] UNIV MANCHESTER, HOPE HOSP, DEPT GERIATR MED, SALFORD M6 8HD, LANCS, ENGLAND
关键词
lung cancer; vascularity; microvasculature; age; tumour volume; prognosis;
D O I
10.1038/bjc.1997.562
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lung tumours in the elderly show reduced growth potential; impaired angiogenesis may contribute to this phenomenon. Recent studies have suggested that the angiogenic potential of a tumour may be inferred by the vascularity measured in histological sections. The purpose of this study has been to determine whether vascularity is related to age, survival or other clinical parameters in resected non-small-cell lung cancer (NSCLC). A group of 88 consecutive patients with a follow-up period of at least 5 years was selected. The group exhibited a wide age range (37-78 years) and similar survival characteristics to those of the general NSCLC population. Tumour sections were stained with a pan-endothelial antibody (vWF) and vascularity was quantitated, without knowledge of the clinical details, by three methods: highest microvascular density, average microvascular density; and average microvascular volume. The results were analysed by non-parametric statistical tests. A correlation was found between all three methods of quantitation. Vascularity was not associated with age, sex, tumour type, stage, volume, size (TNM-T) nodal status (TNM-N) or survival. However, survival time was generally longer for patients with higher vascularity, reaching borderline significance (P = 0.06) for the average microvascular density values. Higher tumour volume (P = 0.02) and stage (P = 0.05) were associated with lower survival times. Using multivariate survival analysis, tumour volume was the only factor related to survival. We conclude that vascularity is not associated with age and has no significant prognostic value in NSCLC.
引用
收藏
页码:1367 / 1375
页数:9
相关论文
共 47 条
  • [1] [Anonymous], 1982, AM J CLIN PATHOL, V77, P123
  • [2] TUMOR ANGIOGENESIS AS A PROGNOSTIC ASSAY FOR INVASIVE DUCTAL BREAST-CARCINOMA
    AXELSSON, K
    LJUNG, BME
    MOORE, DH
    THOR, AD
    CHEW, KL
    EDGERTON, SM
    SMITH, HS
    MAYALL, BH
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (13) : 997 - 1008
  • [3] BOSSI P, 1995, CANCER RES, V55, P5049
  • [4] BUSAM KJ, 1995, AM J PATHOL, V147, P1049
  • [5] BYRNE A, 1995, LUNG CANCER, P267
  • [6] CLINICAL PROGNOSTIC-SIGNIFICANCE OF TUMOR ANGIOGENESIS
    CRAFT, PS
    HARRIS, AL
    [J]. ANNALS OF ONCOLOGY, 1994, 5 (04) : 305 - 311
  • [7] DAVIDSON SE, 1994, INT J ONCOL, V5, P639
  • [8] deJong JS, 1995, LAB INVEST, V73, P922
  • [9] THE INFLUENCE OF AN AGING IMMUNE-SYSTEM ON CANCER INCIDENCE AND PROGRESSION
    ERSHLER, WB
    [J]. JOURNALS OF GERONTOLOGY, 1993, 48 (01): : B3 - B7
  • [10] WHAT IS THE EVIDENCE THAT TUMORS ARE ANGIOGENESIS DEPENDENT
    FOLKMAN, J
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (01): : 4 - 6